4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 680.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 750.00
  • 52 Week Low: 400.00
  • Currency: UK Pounds
  • Shares Issued: 12.32m
  • Volume: 0
  • Market Cap: £83.77m

Latest ShareCast News

4basebio enters neurofibromatosis collaboration with two universities

By Josh White

Date: Friday 10 Jun 2022

(Sharecast News) - Life sciences company 4basebio announced a collaboration with the University of Alabama (UA) and Teesside University (TU) on Friday, in a research project aimed at developing an effective treatment for neurofibromatosis type-1 (NF1).

Losses to continue as 4basebio focuses on commercialisation

By Josh White

Date: Monday 09 May 2022

(Sharecast News) - Specialist DNA-focussed life sciences company 4basebio reported revenue of £0.34m in its final results on Monday, down from £0.46m year-on-year.

4basebio inks development deal with Heqet Therapeutics

By Josh White

Date: Wednesday 27 Apr 2022

(Sharecast News) - Life sciences company 4basebio announced a joint development agreement with Heqet Therapeutics on Wednesday.

4basebio launches two new synthetic DNA products 23-Mar-2022 ShareCast
4basebio makes progress with manufacturing devel... 15-Feb-2022 ShareCast
4basebio enters research collaboration with eThe... 18-Jan-2022 ShareCast
4basebio enters development deal with T-cell the... 23-Nov-2021 ShareCast
4basebio files for patent on novel DNA type 22-Jun-2021 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 680.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 750.00
52 Week Low 400.00
Volume 0
Shares Issued 12.32m
Market Cap £83.77m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.6% below the market average61.6% below the market average61.6% below the market average61.6% below the market average61.6% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average
Price Trend
95.46% above the market average95.46% above the market average95.46% above the market average95.46% above the market average95.46% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
7.2% below the market average7.2% below the market average7.2% below the market average7.2% below the market average7.2% below the market average
Sector averageSector averageSector averageSector averageSector average

4basebio Dividends

No dividends found

Trades for --2023

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page